Dublin, Ireland, 7th May 2020: As the total number of recorded COVID-19 cases rises to 21,772 in Ireland, senior respiratory consultants from hospitals across the country – led by Professor Richard Costello – have collaborated on the development and deployment of a new clinical support tool, designed to help support healthcare professionals with triage, monitoring, and treatment of coronavirus patients.
ACORRD – which stands for the Assessment of COVID-19 Risk of Respiratory Deterioration – is the result of round-the-clock efforts by clinicians and Dublin-based digital health solutions provider S3 Connected Health; supported by The Royal College of Surgeons in Ireland (RCSI) and The Royal College of Physicians in Ireland (RCPI).
Following receipt of a derogation from the HPRA and the Department of Health, ACORRD reached doctors at Beaumont Hospital, which has the largest cohort of COVID-19 patients in Ireland, in a record 10 days. Three more major hospitals are currently using ACCORD with over 100 clinicians piloting the use of the solution on over 1,000 patients.
Following a successful review of the clinical benefits of the solution by the HSE, ACORRD is now being rolled out to hospitals across the Irish healthcare system.
Professor Richard Costello, senior respiratory consultant, Beaumont Hospital – lead clinician on the ACORRD project – commented: “Ireland’s hospitals are working tirelessly and doing a stellar job at looking after coronavirus patients. However, with the number of cases rapidly increasing, we urgently needed to find a solution which enabled our hospital teams to cope with this crisis by optimising and scaling acute respiratory care delivery for all affected patients. And with additional clinical staff being pulled in from other departments to boost our respiratory care teams, we also needed something to provide clinicians less experienced in this area with the critical knowledge and decision support to care for patients.”
Fran Thompson, Chief Information Officer Health Service Executive (HSE), commented:“Delivering digitally enabled safe health care is a key part of our Covid response. The HSE is committed to collaborating with all partners in healthcare to improve patient clinical outcome and experience. The ability to manage and support clinical workflow with a digitally enabled process is crucial to creating a modern health service.”
Martin Curley, Director of Digital Transformation & Open Innovation, Health Service Executive (HSE), commented: “The development of ACORRD and the speed of collaboration on this project is testament to the team of clinicians and developers from RCSI, RCPI, and S3 Connected Health. All parties answered the emergency call to action and this project is an exemplar for agile development. With strong clinical support for ACORRD, the HSE is working with S3 Connected Health to deploy the solution in the Irish Acute healthcare system.”
Jim O’Donoghue, President, S3 Connected Health, commented: “In normal service, creating ACORRD would take up to a year, from developing the concept through to deployment. However, as these are critical times, we managed to expedite the process – by building upon our existing Affinial platform, which underpins all our digital health solutions – and deliver it in less than two weeks, thanks to our outstanding partners.
“Digital health solutions are becoming a vital part of today’s healthcare system, and the COVID-19 crisis underlines the importance of embracing digital solutions to improve patient outcomes and facilitate more efficient care.”
What is ACORRD, and how does it work?
The solution – which enables clinicians to quickly and appropriately triage COVID-19 patients using the web-based application on their smartphone – defines a novel measure of patient status called the COVID Critical Care Index (CCCI), and helps determine the best course of treatment based on:
CCCI assessments are repeated on an ongoing basis, enabling ACORRD to visualise trends, track disease progression, assist in the early identification of patient deterioration, and provide timely advice to the care team on the appropriate clinical considerations.
What impact will ACORRD have on the COVID-19 pandemic?
ACORRD is designed to:
Costello continued: “The adoption we’ve seen from clinicians has been very encouraging; non-respiratory clinicians, in particular, are finding it a very valuable resource. We are also starting to see some interesting clinical data from ACORRD, which is helping us better understand the trajectory of the disease and help plan for future requirements; to have the insight into the progression of this uncharted disease is invaluable.”
– ENDS –
S3 Connected Health partners with pharma, medtech, and healthcare providers to create and operate digital health solutions and connected medical devices that improve the lives of people with acute and chronic conditions.
They specialize in digital therapeutics, digital therapy management solutions, and medical device software to capture real-world data and create insights that enhance operational efficiency, clinical effectiveness, and patient services.
Using experience mapping and behavioral science techniques to fully understand the needs of patients, clinicians, payors, and providers, they create custom solutions that improve healthcare delivery.
For over 18 years, in over 50 countries, across 20 therapy areas, S3 Connected Health have delivered award-winning solutions that are scalable, secure, and regulatory compliant.
For more information visit www.S3ConnectedHealth.com.
Rebecca Mulgrave, Branch Road for S3 Connected Health
Peter Myler, S3 Connected Health